Digestive System

Completion of the proposed studies will correlate the specific genes, proteins, nucleic acids or bacterial species with gastrointestinal, pancreato-biliary and hepatology disorders, including but not limited to cancer.  A secondary point will be to determine whether specific biomarkers found in bodily fluids or tissue predict qualitative and quantitative changes in metabolic pathways.

Primary disease category: 

The purpose of this study is to evaluate the safety of different doses of risankizumab and determine how well it works in subjects with moderate to severe Crohn’s disease.

Primary disease category: 
Secondary disease category(ies): 

The purpose of this study is to evaluate the safety of different doses of risankizumab and determine how well it works in subjects with moderate to severe Crohn disease.

Primary disease category: 
Secondary disease category(ies): 
Subscribe to RSS - Digestive System